Immune response against Sporothrix schenckii in TLR-4-deficient mice

Micheli Fernanda Sassá1, Lucas Souza Ferreira, Livia Carolina de Abreu Ribeiro

  • 1Laboratory of Clinical Immunology, School of Pharmaceutical Sciences, São Paulo State University, São Paulo, Brazil.

Mycopathologia
|January 31, 2012
PubMed

Insights

Toll-like receptor 4 (TLR-4) is crucial for macrophage activation against fungal infections like sporotrichosis. Its absence impairs inflammatory responses, potentially due to increased TGF-β signaling.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Macrophages are key in combating fungal infections through phagocytosis.
  • Toll-like receptors (TLRs), particularly TLR-4, are vital for recognizing fungal pathogens and initiating immune responses.
  • TLR-4 deficiency is linked to increased susceptibility to various fungal infections.

Purpose of the Study:

  • To investigate the role of TLR-4 signaling in the inflammatory response during Sporothrix schenckii infection.
  • To evaluate the impact of TLR-4 deficiency on H2O2 production and cytokine release (IL-1β, IL-6, TGF-β) in a murine model of sporotrichosis.

Main Methods:

  • Utilized TLR-4-deficient mice to model sporotrichosis.
  • Assessed inflammatory markers including hydrogen peroxide (H2O2) production.
  • Quantified the release of key cytokines: interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and transforming growth factor-beta (TGF-β).

Main Results:

  • Macrophages demonstrated significant dependence on TLR-4 for inflammatory activation.
  • Mice lacking TLR-4 exhibited abrogated inflammatory activation of peritoneal exudate cells.
  • Increased release of TGF-β was observed in TLR-4-deficient conditions during S. schenckii infection.

Conclusions:

  • TLR-4 signaling is essential for effective macrophage-mediated inflammatory responses against Sporothrix schenckii.
  • The absence of TLR-4 signaling leads to impaired immune activation in sporotrichosis.
  • Elevated TGF-β levels may contribute to the suppressed inflammatory response in TLR-4-deficient mice, highlighting a potential therapeutic target.